Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005-2006

The Journal of Infectious Diseases
Gui LiuElizabeth R Unger

Abstract

A 9-valent human papillomavirus (HPV) vaccine, licensed in 2014, prevents 4 HPV types targeted by the quadrivalent vaccine (6/11/16/18) and 5 additional high-risk (HR) types (31/33/45/52/58). Measuring seropositivity before vaccine introduction provides baseline data on exposure to types targeted by vaccines. We determined seroprevalence of HPV 6/11/16/18/31/33/45/52/58 among 4943 persons aged 14-59 years who participated in the National Health and Nutrition Examination Survey, 2005-2006. Among females, seroprevalence was 40.5% for any of the 9 vaccine types, 30.0% for any 7 HR types (16/18/31/33/45/52/58), 19.0% for any 5 additional types (31/33/45/52/58), and 18.3% for 16/18. Compared with non-Hispanic whites, non-Hispanic blacks had higher seroprevalence of 31/33/45/52/58 (36.8% vs 15.9%) and 16/18 (30.1% vs 17.8%), while Mexican Americans had higher seroprevalence of 31/33/45/52/58 (23.6% vs 15.9%) (P < .05 for all). In multivariable analyses of data from females, race/ethnicity, number of sex partners, and age were associated with 16/18 and 31/33/45/52/58 seropositivity. Seropositivity was lower among males than among females (P < .001 for all type categories). In 2005-2006, about 40% of females and 20% of males had serolo...Continue Reading

References

Oct 24, 2007·The Journal of Infectious Diseases·Jeffrey M PartridgeLaura A Koutsky
Oct 19, 2010·The Lancet Oncology·Silvia de SanjoseUNKNOWN Retrospective International Survey and HPV Time Trends Study Group
Jun 16, 2011·The Journal of Infectious Diseases·Zoe R EdelsteinLaura A Koutsky
Sep 9, 2011·Journal of the National Cancer Institute·Hui-Chi ChenUNKNOWN CBCSP-HPV Study Group
Feb 11, 2012·International Journal of Cancer. Journal International Du Cancer·Peng GuanGary M Clifford
Jun 26, 2012·International Journal of Cancer. Journal International Du Cancer·Long Fu XiNancy B Kiviat
Oct 10, 2012·The Journal of Infectious Diseases·Susan HaririUNKNOWN HPV-IMPACT Working Group
Dec 5, 2012·Vaccine·David FormanSilvia Franceschi
Dec 5, 2012·Vaccine·John T SchillerSuzanne M Garland
Dec 5, 2012·Vaccine·John DoorbarMargaret A Stanley
Jan 1, 2013·Infectious Agents and Cancer·Beatriz SerranoSilvia de Sanjosé
Feb 14, 2013·Sexually Transmitted Diseases·Catherine Lindsey SatterwhiteHillard Weinstock
Oct 10, 2014·Sexually Transmitted Diseases·Harrell W ChessonLauri E Markowitz
Nov 25, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Susan HaririLauri E Markowitz
Nov 27, 2014·Human Vaccines & Immunotherapeutics·Christine RobertsJoseph Antonello
Dec 17, 2014·Sexually Transmitted Diseases·Gui LiuLauri E Markowitz
Feb 19, 2015·The New England Journal of Medicine·Elmar A JouraUNKNOWN Broad Spectrum HPV Vaccine Study
May 1, 2015·Journal of the National Cancer Institute·Mona SaraiyaUNKNOWN HPV Typing of Cancers Workgroup

❮ Previous
Next ❯

Citations

Feb 6, 2016·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Walter W WilliamsCarolyn B Bridges
Sep 1, 2015·The Journal of Infectious Diseases·Patti E Gravitt
Mar 25, 2016·The Journal of Infectious Diseases·Aaron C Ermel, Kenneth H Fife
Feb 9, 2017·The Journal of Infectious Diseases·Patti E Gravitt
May 5, 2017·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Walter W WilliamsAmy Parker Fiebelkorn
Mar 13, 2018·The Journal of Infectious Diseases·Hanna ArtemchukHelena Faust
Jun 28, 2018·Genes & Development·Erica A GolemisNancy Hopkins
Nov 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Rayleen M LewisElizabeth R Unger
Feb 23, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Admire ChikandiwaSinead Delany-Moretlwe
Aug 31, 2019·Epidemiology and Infection·Reyna Lizette Pacheco-DomínguezMalaquías López-Cervantes
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alexis J PillsburyJulia M L Brotherton
Aug 29, 2020·Vaccines·Mauro TognonFernanda Martini
Oct 9, 2020·Obstetrics and Gynecology·Lital Avni-SingerSangini S Sheth
Mar 16, 2021·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Lital Avni-SingerSangini S Sheth
Jul 16, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph E TotaJoel M Palefsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.